Thomas Graney
Director/Board Member at Mogrify Ltd.
Net worth: 40 247 $ as of 31/05/2024
Profile
Thomas Graney is currently a Non-Executive Director at Mogrify Ltd.
and an Independent External Director at Notable Labs Ltd.
Previously, he served as the Chief Executive Officer & Director at Oxurion NV, an Independent Non-Executive Director at AC Immune SA, and the Chief Financial Officer & Senior Vice President at Vertex Pharmaceuticals, Inc. He also held positions as the CFO, Senior VP-Finance & Corporate Strategy at Ironwood Pharmaceuticals, Inc. and the Chief Financial Officer & Vice President-Finance at Ethicon, Inc. Additionally, he was the Chief Financial Officer at Tibotec Pharmaceuticals.
Mr. Graney received his undergraduate degree from the University of Delaware and an MBA from The Leonard N Stern School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.45% | 08/05/2024 | 40,247 ( 0.45% ) | 40 247 $ | 31/05/2024 |
Thomas Graney active positions
| Companies | Position | Start |
|---|---|---|
Mogrify Ltd.
 Mogrify Ltd. BiotechnologyHealth Technology Mogrify Ltd. engages in the development of direct cellular conversion technology. It applies its technology to generate internet protocol and cell types that will power the development and manufacture of new cell therapies in any therapeutic area. The company was founded by Julian Gough, Owen John Llewellyn Rackham, and Jose Polo in 2009 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 02/11/2021 |
Former positions of Thomas Graney
| Companies | Position | End |
|---|---|---|
| OXURION NV | Chief Executive Officer | 28/12/2023 |
| AC IMMUNE SA | Director/Board Member | 01/01/2023 |
| VERTEX PHARMACEUTICALS INCORPORATED | Director of Finance/CFO | 13/12/2018 |
| IRONWOOD PHARMACEUTICALS, INC. | Director of Finance/CFO | 13/09/2017 |
Ethicon, Inc.
 Ethicon, Inc. Medical SpecialtiesHealth Technology Ethicon, Inc. develops and markets medical products and devices for surgery. It offers different types of services such as wound management, women's health, and cardiovascular surgery. The company was founded by George F. Merson in 1915 and is headquartered in Somerville, NJ. | Director of Finance/CFO | 01/08/2014 |
Training of Thomas Graney
| University of Delaware | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| AC IMMUNE SA | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| GENERATION BIO CO. | Health Technology |
| OXURION NV | Health Technology |
| Private companies | 3 |
|---|---|
Ethicon, Inc.
Ethicon, Inc. Medical SpecialtiesHealth Technology Ethicon, Inc. develops and markets medical products and devices for surgery. It offers different types of services such as wound management, women's health, and cardiovascular surgery. The company was founded by George F. Merson in 1915 and is headquartered in Somerville, NJ. | Health Technology |
| Tibotec Pharmaceuticals | |
Mogrify Ltd.
Mogrify Ltd. BiotechnologyHealth Technology Mogrify Ltd. engages in the development of direct cellular conversion technology. It applies its technology to generate internet protocol and cell types that will power the development and manufacture of new cell therapies in any therapeutic area. The company was founded by Julian Gough, Owen John Llewellyn Rackham, and Jose Polo in 2009 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Thomas Graney
